Knowledge Center

View all:

Fact Sheets

Most Recent

TIMIZA90 Project Factsheet

Timiza90 is a five-year (Oct 2016 to Sept 2021) U.S. Centres for Disease Control and Prevention (CDC)-funded Project which aims to support the implementation and expansion of high quality, sustainable, and comprehensive HIV prevention, care, and treatment programs.

View All Fact Sheets

Issue Briefs

Most Recent

Improving Access to HIV Care & Treatment Through Decentralization & Integration in Kenya

This brief focuses on EGPAF’s Pamoja Project in Homabay in the four sub-counties in which the project operated, during the period October 2010 to September 2016.

View All Issue Briefs

Technical Briefs

Most Recent

Improving Access to HIV Care & Treatment Through Decentralization & Integration in Kenya

This brief focuses on EGPAF’s Pamoja Project in Homabay in the four sub-counties in which the project operated, during the period October 2010 to September 2016.

View All Technical Briefs

Technical Bulletins

Most Recent

Spotlight on Treatment for All

The World Health Organization released recommendations in 2015 to ensure all HIV-positive persons, regardless of disease status, initiated lifelong treatment. In this issue of Haba Na Haba, EGPAF explores the impact of this all-inclusive treatment protocol, best practices in growing treatment access in our own supported countries and charts a way forward to effectively implement these new guidelines in a variety of settings.

View All Technical Bulletins

Technical Reports

Most Recent

PAMOJA: Supporting the Implementation and Expansion of High Quality HIV Prevention, Care, and Treatment Activities at Facility and Community Level in Kenya

This report focuses on The U.S. Centers for Disease Control and Prevention (CDC)-funded Pamoja Project (2010–2016), which strengthened management, oversight, and implementation of high-quality integrated, comprehensive, and sustainable HIV services in Kenya. Through Pamoja, the Elizabeth Glaser Pediatric AIDS Foundation in Kenya (EGPAF-Kenya) integrated the delivery of HIV prevention, care, and treatment services into maternal, neonatal, and child health (MNCH) settings, tuberculosis (TB) units, and general health service delivery sites to improve client access to and retention in HIV care and treatment.

View All Technical Reports

Journal Articles

Most Recent

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

Randomized-trial data on the risks and benefits of antiretroviral therapy (ART) as compared with zidovudine and single-dose nevirapine to prevent transmission of the human immunodeficiency virus (HIV) in HIV-infected pregnant women with high CD4 counts are lacking.

View All Journal Articles

Program Tools

Most Recent

Advocacy Tool Kit on Pediatric HIV Treatment

In partnership with the Organization of African First Ladies against HIV/AIDS (OAFLA), the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) developed a tool kit on pediatric HIV treatment to guide African First Ladies in their advocacy efforts in country and within the region.  With this toolkit, the First Ladies Offices have statistics, messages and key actions that they can undertake to advocate on pediatric HIV treatment. The tool kit touches on key areas important to addressing pediatric HIV treatment, including: PMTCT, early infant diagnosis (EID) and linkage to care, pediatric formulations, and stigma and discrimination. This toolkit will facilitate the achievement of the goals that OAFLA has developed in its strategic plan of 2014-2018. The Pediatric HIV Tool Kit was presented by EGPAF during a capacity building workshop for Technical Advisers to the First Ladies in Addis Ababa, Ethiopia on January 27, 2016.

View All Program Tools